Haiti vs Kyrgyzstan: Death rate from cancer
Haiti
66.67 deaths per 100,000 people
in 2021
Kyrgyzstan
64.71 deaths per 100,000 people
in 2021
Haiti rank
126th
Kyrgyzstan rank
129th
Death rate from cancer over time
- Haiti
- Kyrgyzstan
How they compare
Haiti currently reports 66.67 deaths per 100,000 people against 64.71 deaths per 100,000 people in Kyrgyzstan, a difference of 1.96 deaths per 100,000 people.
The two have swapped places 1 time across 22 shared years of data; in 2000 it was Kyrgyzstan ahead.
Haiti ranks 126th and Kyrgyzstan ranks 129th of 194 countries.
Across the 3 decades both report, Haiti averaged higher in 2 and Kyrgyzstan in 1.
Head to head by decade
| Decade | Haiti | Kyrgyzstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 70.71 deaths per 100,000 people | 71 deaths per 100,000 people | 0.299 deaths per 100,000 people | Kyrgyzstan |
| 2010s | 74.51 deaths per 100,000 people | 66.88 deaths per 100,000 people | 7.63 deaths per 100,000 people | Haiti |
| 2020s | 68.42 deaths per 100,000 people | 66.06 deaths per 100,000 people | 2.36 deaths per 100,000 people | Haiti |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from cancer, Haiti or Kyrgyzstan?
- Haiti, at 66.67 deaths per 100,000 people against 64.71 deaths per 100,000 people in Kyrgyzstan as of 2021.
- What is the difference in death rate from cancer between Haiti and Kyrgyzstan?
- 1.96 deaths per 100,000 people, with Haiti ahead.
- How many years of comparable data are there for Haiti and Kyrgyzstan?
- 22 years are reported by both, from 2000 to 2021.
- How do Haiti and Kyrgyzstan rank globally for death rate from cancer?
- Haiti ranks 126th and Kyrgyzstan ranks 129th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Death rate from cancer. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from malignant neoplasms in both sexes, per 100,000 people.